Compare HALO & NVMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HALO | NVMI |
|---|---|---|
| Founded | 1998 | 1993 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 12.6B |
| IPO Year | 2001 | 2001 |
| Metric | HALO | NVMI |
|---|---|---|
| Price | $107.93 | $387.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 8 |
| Target Price | $99.56 | ★ $532.00 |
| AVG Volume (30 Days) | ★ 2.0M | 403.7K |
| Earning Date | 11-02-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.11 | N/A |
| Revenue | ★ $151,862,000.00 | N/A |
| Revenue This Year | $32.72 | $22.39 |
| Revenue Next Year | $10.61 | $26.21 |
| P/E Ratio | ★ $36.16 | $56.79 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $61.23 | $266.43 |
| 52 Week High | $116.85 | $615.99 |
| Indicator | HALO | NVMI |
|---|---|---|
| Relative Strength Index (RSI) | 54.81 | 57.33 |
| Support Level | $104.49 | $332.52 |
| Resistance Level | $111.15 | $387.71 |
| Average True Range (ATR) | 3.04 | 10.54 |
| MACD | -0.71 | 5.55 |
| Stochastic Oscillator | 42.53 | 92.25 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Nova Ltd is a provider of metrology and process control solutions used in semiconductor manufacturing. The company provides high-performance metrology solutions across the semiconductor fabrication lifecycle and develops differentiated inline metrology solutions deployed by a broad range of customers, including integrated circuit manufacturers. Its portfolio combines high-precision hardware and software, enabling customers to improve device performance, enhance yields, and accelerate time to market. Its products include Dimensional Metrology, Materials Metrology, Chemical Metrology, and Software Solutions. The company operates in China, Taiwan, R.O.C., the United States and other regions, with maximum revenue coming from China.